Pharmaceuticals

Pharmaceutical Continuous Manufacturing Market Trends 2025–2029: Forecasts for Key Growth Segments

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Pharmaceutical Continuous Manufacturing Market Over The Five-Year Period 2025–2029?

The pharmaceutical continuous manufacturing market size has shown substantial growth in recent years. It is anticipated to expand from $2.47 billion in 2024 to $2.69 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.2%. The increase observed in the historic period can be credited to enhancements in quality and efficiency, a shorter time-to-market, reduced costs and improved operational efficiency, favorable regulatory support and guidelines, and increased flexibility and scalability.

The pharmaceutical continuous manufacturing market is expected to experience significant growth in the coming years. It is projected to expand to $4.08 billion by 2029, with a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is driven by increasing generic drug production, advancements in biopharmaceutical manufacturing, the development of personalized medicine, and a heightened focus on patient-centric approaches. Notable trends for the forecast period include the adoption of continuous manufacturing, the integration of process analytical technology, the utilization of advanced automation and robotics, strategic collaborations and partnerships, and increased digitalization and connectivity.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp

What Are The Drivers Pushing New Developments In The Pharmaceutical Continuous Manufacturing Market?

The increasing occurrence of various chronic ailments is anticipated to propel the growth of the pharmaceutical continuous manufacturing market going forward. These conditions are generally characterized as health issues that persist for a year or longer, require ongoing medical treatment, and interfere with everyday activities. Continuous manufacturing processes enable pharmaceutical companies to streamline medication production, leading to enhanced efficiency and reduced costs. This approach also ensures broader access to essential drugs, which is particularly crucial for managing chronic conditions that necessitate long-term medication use. For instance, in April 2022, a report published by the National Association of Chronic Disease Directors (NACDD), a US-based non-profit Public Health organization dedicated to chronic disease programs, revealed that almost 60 % of adult Americans have at least one chronic disease, and approximately 40% of American adults have multiple chronic conditions (MCC). This is expected to cost the US economy $2 trillion annually, or $8,600 per person, by 2030. Therefore, the growing prevalence of several chronic ailments will drive the pharmaceutical continuous manufacturing market.

What Are The Emerging Segments Gaining Attention In The Pharmaceutical Continuous Manufacturing Market?

The pharmaceutical continuous manufacturing market covered in this report is segmented –

1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System

2) By Therapeutics Type: Large Molecule, Small Molecule

3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation

4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing

5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users

Subsegments:

1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems

2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software

3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems

What Are The Major Trends Driving The Growth Of The Pharmaceutical Continuous Manufacturing Market?

Technological advancements are a significant trend growing in popularity within the pharmaceutical continuous manufacturing market. Major companies operating in the pharmaceutical continuous manufacturing market are introducing new products to maintain their market position. For instance, in December 2022, The United States Pharmacopeia (USP), a US-based nonprofit organization that owns the trademark and copyright for the Pharmacopeia National Formulary (USP-NF), unveiled the USP Advanced Manufacturing Technology Lab, complete with R&D analytical solutions. These analytical lab services are designed to help drug manufacturers adopt sophisticated manufacturing technologies, like pharmaceutical continuous manufacturing (PCM), to enhance geographic diversity in pharmaceutical production and strengthen the resilience of the medicine supply chain. This initiative aims to characterize materials and establish and qualify methods to support and ensure the quality of PCM-based medications.

Which Leading Players Are Enhancing Their Pharmaceutical Continuous Manufacturing Market Presence Worldwide?

Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-continuous-manufacturing-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Pharmaceutical Continuous Manufacturing Market?

Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceutical Continuous Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Continuous Manufacturing Market 2025, By The Business Research Company

Synthetic Rubber And Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-rubber-and-fibers-global-market-report

Styrene Butadiene Rubber Sbr Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report

Rubber Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rubber-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795